0001609251-21-000004.txt : 20210518 0001609251-21-000004.hdr.sgml : 20210518 20210517210125 ACCESSION NUMBER: 0001609251-21-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210517 EFFECTIVENESS DATE: 20210518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 21933465 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001609251 XXXXXXXX 03-31-2021 03-31-2021 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 Paul J. Paolino New York NY 05-17-2021 0 12 288899 false INFORMATION TABLE 2 Krensavage_Form13F03312021.xml KRENSAVAGE FORM 13F 03.31.2021 ALKERMES PLC COM G01767105 30398 1627323 SH SOLE 1627323 0 0 ALEXION PHARMACEUTICALS INC COM 015351109 1057 6912 SH SOLE 6912 0 0 ANAPTYSBIO INC COM 032724106 554 25690 SH SOLE 25690 0 0 BIOGEN INC COM 09062X103 38750 138518 SH SOLE 138518 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 42556 862848 SH SOLE 862848 0 0 INVACARE CORP COM 461203101 7284 908236 SH SOLE 908236 0 0 MCKESSON CORP COM 58155Q103 32697 167640 SH SOLE 167640 0 0 NEXTCURE INC COM 65343E108 306 30603 SH SOLE 30603 0 0 REGENERON PHARMACEUTICALS COM 75886F107 39128 82698 SH SOLE 82698 0 0 SURGALIGN HOLDINGS INC COM 86882C105 14060 6449408 SH SOLE 6449408 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 40388 547639 SH SOLE 547639 0 0 UNITED THERAPEUTICS CORP COM 91307C102 41721 249421 SH SOLE 249421 0 0